REPATH LAUNCH
15 September 2026
Global
REPATH — Genspect's Re-psychopathologisation Campaign — launches today, and Beyond Gender marks the occasion with a dedicated episode from Stella O'Malley and Mia Hughes. The campaign calls for reinstating a psychiatric framework around transgender ideation, not gender non-conformity, so that thorough differential diagnosis and genuine psychological care replace automatic affirmation. For a continent where Sweden, Finland, the Netherlands and France are already reassessing affirmation-only pathways, REPATH arrives at a pivotal moment and gives European clinicians a shared language for reforms many are quietly pursuing.
On 15 September 2026, Genspect launched REPATH — its Re-psychopathologisation Campaign — and the Beyond Gender podcast marked the occasion with a dedicated launch-day episode hosted by Stella O'Malley and Mia Hughes. REPATH's argument is precise and deliberate: it calls not for the pathologisation of gender non-conformity, but for reinstating a psychiatric understanding of transgender ideation, so that patients receive thorough differential diagnosis and appropriate psychological or psychiatric care rather than an automatic path to medical transition. The episode gives O'Malley and Hughes the space to unpack what that distinction means in practice. Gender non-conformity — dressing differently, feeling at odds with social expectations, moving through the world in ways that don't map to conventional sex roles — is not the target. The target is the clinical habit, now deeply embedded in many healthcare systems, of treating a young person's stated gender identity as both self-evident truth and sufficient grounds for a medical pathway. REPATH argues this habit has displaced the careful, open-ended psychological enquiry that once defined good clinical care. For listeners across continental Europe, the timing could hardly be more significant. Sweden's Karolinska Institute effectively ended routine puberty blocker treatment for minors in 2022. Finland's Council for Choices in Health Care followed with strict new guidelines. The Netherlands — home of the original Dutch protocol that shaped a generation of international practice — is conducting a formal review of its paediatric gender services. France, Germany and Denmark have each seen substantial professional and political debate about the evidence base for affirmation-only approaches. REPATH does not arrive into a vacuum: it lands at a moment when European medicine is already asking the questions the campaign is designed to answer. What REPATH adds is a structured, campaigning framework that gives European clinicians something to stand behind. Psychiatrists and psychologists who have privately doubted whether a single appointment and a self-report are sufficient grounds for onward referral now have a named position and an international network to join. For the many clinicians across the EU who feel institutional pressure to affirm before they assess, the campaign offers both conceptual clarity and professional solidarity. The broader stakes touch EU institutions directly. The European Commission's health directives, the Council of Europe's guidance on trans healthcare, and the ongoing influence of the WHO's ICD-11 classification — which relocated gender incongruence away from mental health categories — all bear on how member states design their clinical pathways. REPATH's call for restored psychiatric engagement is, among other things, a contribution to that supranational policy conversation, and European health ministries will be watching closely. Beyond Gender's decision to dedicate a full episode to the REPATH launch signals that this campaign is being treated as a turning point. For European listeners — parents navigating referral systems, clinicians working under conflicting guidelines, or policymakers weighing contested evidence — the episode is a clear orientation to a campaign that may reshape the vocabulary of gender medicine across the continent in the months ahead.
